Is there a domestic version of ruxolitinib phosphate (JAKAVI) tablets and its market status

Ruxolitinib phosphate (JAKAVI) tablets are a targeted drug mainly used to treat myelofibrosis and polycythemia vera, and are JAK inhibitors. The drug regulates abnormal cell proliferation by inhibiting the Janus kinase (JAK) signaling pathway, thereby effectively controlling the development of related hematological diseases. At present, ruxolitinib tablets have been officially launched in China, bringing more treatment options to patients.

Regarding the domestic version, ruxolitinib tablets are currently mainly imported and sold by the original manufacturer, and a completely domestic version has not yet been widely launched in China. However, with the advancement of domestic innovative drug research and development, more domestic generic or innovative versions are expected to appear in the future to meet the medication needs of domestic patients. At this stage, patients mainly purchase imported original drugs through regular hospitals and pharmacies to ensure drug quality and therapeutic effects.

The price of ruxolitinib tablets is relatively high, with the price of a single tablet being about 3,000 yuan, and it has been included in the reimbursement scope of domestic medical insurance. Due to the relatively high price, patients need to consider local medical insurance policies and personal financial conditions when purchasing drugs, and consult the hospital pharmacy for specific reimbursement ratios and actual out-of-pocket expenses. The inclusion of medical insurance has greatly alleviated patients' financial pressure and improved the accessibility of drugs.
In the international market, in addition to original drugs, there are also more affordable generic drug options. For example, the price of original ruxolitinib tablets on the Turkish market is about 4,000 yuan, while the price of generic drugs produced in Bangladesh is only a few hundred yuan, and the ingredients are basically the same as the original drug. These generic drugs provide patients with an affordable alternative, but they need to pay attention to drug quality and legal compliance when purchasing to ensure drug safety.
Reference: https://www.jakavi.com/